All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; e-mail: tni.ohw@snoissimrep).
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This document reviews the medical eligibility criteria for use of contraception, offering guidance on the safety of use of different methods for women and men with specific characteristics or known medical conditions. The recommendations are based on systematic reviews of available clinical and epidemiological research. It is a companion guideline to Selected practice recommendations for contraceptive use. Together, these documents are intended to be used by policy-makers, programme managers, and the scientific community, to support national programmes in the preparation of service delivery guidelines.
Contents
- ACKNOWLEDGEMENTS
- EXECUTIVE SUMMARY AND OVERVIEW
- EXECUTIVE SUMMARY
- OVERVIEW
- GOAL
- BACKGROUND
- REPRODUCTIVE AND SEXUAL HEALTH CARE
- ISSUES OF SERVICE QUALITY AND ACCESS THAT AFFECT METHOD USE
- EFFECTIVENESS OF METHOD
- CONDITIONS THAT EXPOSE A WOMAN TO INCREASED RISK AS A RESULT OF UNINTENDED PREGNANCY
- RETURN TO FERTILITY
- STIS AND CONTRACEPTION: DUAL PROTECTION
- METHOD OF WORK
- EVIDENCE IDENTIFICATION AND SYNTHESIS
- HOW TO USE THIS DOCUMENT
- USING THE TABLES
- CLASSIFICATION OF CATEGORIES
- USING THE CATEGORIES IN PRACTICE
- PROGRAMMATIC IMPLICATIONS
- INTRODUCING GUIDELINES INTO NATIONAL PROGRAMMES
- CLIENTS WITH SPECIAL NEEDS
- SUMMARY OF CHANGES FROM THE THIRD EDITION
- COMBINED HORMONAL CONTRACEPTIVES (CHCs)
- PROGESTOGEN-ONLY CONTRACEPTIVES (POCs)
- EMERGENCY CONTRACEPTIVE PILLS (ECPs) (including levonorgestrel contraceptive pills and combined oral contraceptive pills)
- INTRAUTERINE DEVICES (IUDs)
- COPPER IUD FOR EMERGENCY CONTRACEPTION (E-IUD)
- BARRIER METHODS (BARR)
- FERTILITY AWARENESS-BASED METHODS (FAB)
- LACTATIONAL AMENORRHOEA METHOD (LAM)
- COITUS INTERRUPTUS (CI)
- SURGICAL STERILIZATION PROCEDURES (STER)
- SUMMARY TABLES (SUMM)
- ANNEX 1 HORMONAL CONTRACEPTIVES AND ANTIRETROVIRAL THERAPIES
- ANNEX 2 LIST OF PARTICIPANTS
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- Medical Eligibility Criteria for Contraceptive UseMedical Eligibility Criteria for Contraceptive Use
Your browsing activity is empty.
Activity recording is turned off.
See more...